
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Syros Pharmaceuticals
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RAR agonist in frontline patients with higher-risk myelodysplastic syndrome with RARA gene overexpression. For more information, visit www.syros.com and follow us on X (@SyrosPharma) and LinkedIn
C-Level 0 | VP - Level1 |
Director- | Manager5 |
Others43 |
Structure | Email Format |
---|---|
<f><last>@ |
|
Pain Points | Locations | Technologies |
---|---|---|
BI | Cambridge, MA | communication, integrity, analytics, collaboration, forecasting |
BI | United States | communication, integrity, exchange, compliance, e, analytics, collaboration, forecasting |
Compliance | Cambridge, MA | communication, integrity, analytics, collaboration, forecasting |
Compliance | United States | communication, integrity, exchange, compliance, e |
Digital Transformation | Cambridge, MA | communication, integrity, analytics, collaboration, forecasting |
Syros Pharmaceuticals looking to hire in Compliance in United States
Syros Pharmaceuticals looking to hire in Digital Transformation in United States
Syros Pharmaceuticals looking to hire in Networking in United States
Access
Aws
Cisco
Director
Excel
Analytics
Audit
Big data
Collaboration
Communication
Syros is committed to developing new standards of care for the frontline treatment of patients wi...
View MoreSyros is committed to developing new standards of care for the frontline treatment of patients wi...
View MoreSyros is committed to developing new standards of care for the frontline treatment of patients wi...
View MoreSyros is committed to developing new standards of care for the frontline treatment of patients wi...
View MoreSyros is committed to developing new standards of care for the frontline treatment of patients wi...
View MoreSyros is committed to developing new standards of care for the frontline treatment of patients wi...
View MoreSyros is committed to developing new standards of care for the frontline treatment of patients wi...
View MoreSyros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RAR agonist in frontline patients with higher-risk myelodysplastic syndrome with RARA gene overexpression. For more information, visit www.syros.com and follow us on X (@SyrosPharma) and LinkedIn
Syros pharmaceuticals operates in the Pharmaceutical manufacturing industry.
Syros pharmaceuticals's revenue is 101m - 500m
Syros pharmaceuticals has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.